Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
23.74
+5.08 (27.22%)
At close: Nov 6, 2026, 4:00 PM EST
23.50
-0.24 (-1.01%)
After-hours: Nov 6, 2026, 7:30 PM EST

Fulgent Genetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-90.93-60.51-42.71-167.83143.4507.36
Depreciation & Amortization
26.624.1224.9326.1432.6611
Loss (Gain) From Sale of Assets
0.01-00.320.310.50.85
Asset Writedown & Restructuring Costs
12.19.9310.07120.23--
Loss (Gain) From Sale of Investments
-13.29-5.17-4.56-3.325.468.78
Loss (Gain) on Equity Investments
------3.73
Stock-Based Compensation
35.9139.5844.4842.9232.6415.88
Provision & Write-off of Bad Debts
6.037.65-1.73-0.8832.68.93
Other Operating Activities
0.450.4-2.516.594.25-7.83
Change in Accounts Receivable
4.97-23.25-16.32.3968.6442.3
Change in Accounts Payable
-1.570.553.07-6.9-25.34-12.21
Change in Unearned Revenue
0.311.4-0.64-0.33-11.5-
Change in Income Taxes
33.71-104.949.252.76-14.54-52.53
Change in Other Net Operating Assets
0.138.6-2.624.92-15.2519.76
Operating Cash Flow
14.43-101.6421.0627253.52538.58
Operating Cash Flow Growth
847.34%--22.01%-89.35%-52.93%282.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-15.83-22.57-40.32-22.21-18.78-23.81
Sale of Property, Plant & Equipment
0.010.010.310.780.410.06
Cash Acquisitions
-55.853.78--0.4-182.68-61.87
Sale (Purchase) of Intangibles
------0.03
Investment in Securities
96.53130.17-18.3560.73-60.27-460.9
Investing Cash Flow
24.85111.37-58.3538.9-261.31-546.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
----15--
Long-Term Debt Repaid
--0.87-1.77-5-1.07-0.01
Total Debt Repaid
-0.83-0.87-1.77-20-1.07-0.01
Net Debt Issued (Repaid)
-0.83-0.87-1.77-20-1.07-0.01
Issuance of Common Stock
0.0100.0500.0389.56
Repurchase of Common Stock
-69.5-13.92-3.12-27.79-76.11-4.16
Other Financing Activities
-----0.01
Financing Cash Flow
-70.32-14.79-4.85-47.79-77.1485.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.180.11-0.06-0.15-0.450.03
Net Cash Flow
-30.85-4.95-42.1917.97-85.3977.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.4-124.21-19.264.8234.75514.77
Free Cash Flow Growth
----97.96%-54.40%387.94%
Free Cash Flow Margin
-0.42%-38.50%-6.79%1.66%37.92%51.86%
Free Cash Flow Per Share
-0.05-4.04-0.640.167.5816.62
Levered Free Cash Flow
9.73-121.57-25.5724.38197.7454.95
Unlevered Free Cash Flow
9.79-121.53-25.5724.69198.33455.06

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.10.050.510.96--
Cash Income Tax Paid
-96.4527.593.2656.19237.07
Change in Working Capital
37.55-117.63-7.242.842.01-2.68
SEC Filings: 10-K · 10-Q